Status: Recruiting
Taper Or Abrupt Steroid Stop: TOASSTtrial
This study is an Investigator-initiated, placebo-controlled, multicenter noninferiority trial, comparing rapid termination of systemic glucocorticoid treatment with a tapering regime over 4 weeks.
Participants needed: 530
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, Basel, SwitzerlandUpdated: Apr 22, 2026Locations: 16
Eligibility criteria
Informed Consent as documented by signature (Appendix Informed Consent Form) [+4]
Primary adrenal failure [+11]